Literature DB >> 16905307

Background to Eusoma guidelines and statements.

M Greco1, L Marotti.   

Abstract

The European Society of Mastology (Eusoma) is committed in writing and diffusing guidelines on Breast Cancer, aiming at harmonising the quality of Breast Cancer care throughout Europe. To achieve this Eusoma organises scientific meetings, "workshops" or "Consensus meeting", inviting European experts from the different disciplines involved in the multidisciplinary management of Breast Cancer patients, to give their contribution in drafting "guidelines" or "consensus statements". In this regard Eusoma Executive Committee members found it appropriate to define the rules to organise its scientific meetings and to write the documents resulting from these meetings, i.e guidelines or statements. This will guarantee an homogeneity in the meeting organisations and in drawing up the scientific documents.

Entities:  

Mesh:

Year:  2006        PMID: 16905307     DOI: 10.1016/j.ejca.2006.03.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  The Role of Vesicular Stomatitis Virus Matrix Protein in Autophagy in the Breast Cancer.

Authors:  Fatemeh Sana Askari; Alireza Mohebbi; Abdolvahab Moradi; Naeme Javid
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

Review 2.  Benchmarking and audit of breast units improves quality of care.

Authors:  P A van Dam; L Verkinderen; J Hauspy; P Vermeulen; L Dirix; M Huizing; S Altintas; K Papadimitriou; M Peeters; W Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2013

3.  A dynamic clinical pathway for the treatment of patients with early breast cancer is a tool for better cancer care: implementation and prospective analysis between 2002-2010.

Authors:  Peter A van Dam; Gerda Verheyden; Alessa Sugihara; Xuan B Trinh; Herman Van Der Mussele; Hilde Wuyts; Luc Verkinderen; Jan Hauspy; Peter Vermeulen; Luc Dirix
Journal:  World J Surg Oncol       Date:  2013-03-16       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.